Psoriasis
As interest in alternative medicine grows, patients with psoriasis weigh benefits, risks
In this issue of Healio Psoriatic Disease we focus on complementary and alternative medicine for psoriasis.
European Medicines Agency recommends Sotyktu for adults with plaque psoriasis
The European Medicines Agency has recommended the approval of Sotyktu for the treatment of adults with moderate to severe plaque psoriasis, Bristol Myers Squibb announced in a press release.
Spevigo prevents generalized pustular psoriasis flares up to 48 weeks
Spevigo met its primary and key secondary endpoints in a phase 2b trial evaluating the drug for the treatment of adolescents and adults with generalized pustular psoriasis, Boehringer Ingelheim announced in a press release.
Speaker: ‘Localized psoriasis is still important psoriasis’
WAILEA, Hawaii — Treating localized, mild to moderate psoriasis is incredibly important to patients and there are many topical options to utilize in this endeavor, according to a speaker at the Maui Derm meeting.
CAL/BDP cream efficacious in plaque psoriasis treatment for patients with skin of color
WAILEA, Hawaii — A combination calcipotriene and betamethasone dipropionate cream showed similar efficacy in treating plaque psoriasis in patients with skin of color as it did in the full trial population, according to a post-hoc analysis.
Roflumilast-treated patients sustain psoriasis clearance for median 10 months
Once-daily Zoryve showed efficacy and an IGA of clear or almost clear for a median of 10 months in adults with chronic plaque psoriasis, Arcutis Biotherapeutics announced in a press release.
Orismilast achieves positive results in psoriasis, fast track for hidradenitis suppurativa
Union Therapeutics announced positive results for oral orismilast in a phase 2b study in adult patients with moderate to severe psoriasis, and the FDA also granted the drug fast track designation for hidradenitis suppurativa treatment.
More work needed to advance understanding of genetics in psoriasis
It is well known that psoriasis is a complex, multifactorial disease for which the genetic background plays a key role.
Genetics of psoriasis: Clinical practice pearls
In this issue of Healio Psoriatic Disease, we focus on the genetics of psoriasis, a daunting topic for sure! Psoriasis is one of the most heritable of complex genetic trait diseases. Over 65 susceptibility loci have been identified, but 75% of psoriasis heritability is not explained by currently known variants, suggesting there is much more to learn.
Arcutis submits supplemental NDA for Zoryve to treat plaque psoriasis in children
A supplemental new drug application has been submitted to the FDA for Zoryve cream for the treatment of plaque psoriasis in children aged 2 to 11 years, Arcutis Biotherapeutics announced in a press release.